ADVANCED MAGNETICS INC
10-Q, EX-27.1, 2000-08-14
IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES
Previous: ADVANCED MAGNETICS INC, 10-Q, 2000-08-14
Next: RADVA CORP, 10-Q, 2000-08-14



<TABLE> <S> <C>

<PAGE>
<ARTICLE> 5
<CIK> 0000792977
<NAME> ADVANCED MAGNETICS INC.

<S>                             <C>                     <C>
<PERIOD-TYPE>                   3-MOS                   9-MOS
<FISCAL-YEAR-END>                          SEP-30-2000             SEP-30-2000
<PERIOD-START>                             APR-01-2000             OCT-01-1999
<PERIOD-END>                               JUN-30-2000             JUN-30-2000
<CASH>                                      12,362,047                     000
<SECURITIES>                                 6,089,245                     000
<RECEIVABLES>                                  772,389                     000
<ALLOWANCES>                                       000                     000
<INVENTORY>                                     35,296                     000
<CURRENT-ASSETS>                            19,512,360                     000
<PP&E>                                      13,770,661                     000
<DEPRECIATION>                             (9,480,921)                     000
<TOTAL-ASSETS>                              24,223,726                     000
<CURRENT-LIABILITIES>                          613,102                     000
<BONDS>                                            000                     000
                              000                     000
                                        000                     000
<COMMON>                                        67,739                     000
<OTHER-SE>                                         000                     000
<TOTAL-LIABILITY-AND-EQUITY>                24,223,726                     000
<SALES>                                        616,911                 778,441
<TOTAL-REVENUES>                             1,014,033               2,119,630
<CGS>                                           43,195                 106,149
<TOTAL-COSTS>                                1,596,683               5,166,068
<OTHER-EXPENSES>                                   000                     000
<LOSS-PROVISION>                                   000                     000
<INTEREST-EXPENSE>                                 000                     000
<INCOME-PRETAX>                              (582,650)             (3,046,438)
<INCOME-TAX>                                       000                     000
<INCOME-CONTINUING>                                000                     000
<DISCONTINUED>                                     000                     000
<EXTRAORDINARY>                                    000                     000
<CHANGES>                                          000                     000
<NET-INCOME>                                 (582,650)             (3,046,438)
<EPS-BASIC>                                     (0.09)                  (0.45)
<EPS-DILUTED>                                   (0.09)                  (0.45)


</TABLE>


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission